212 related articles for article (PubMed ID: 23250356)
1. Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice.
Leboucher A; Laurent C; Fernandez-Gomez FJ; Burnouf S; Troquier L; Eddarkaoui S; Demeyer D; Caillierez R; Zommer N; Vallez E; Bantubungi K; Breton C; Pigny P; Buée-Scherrer V; Staels B; Hamdane M; Tailleux A; Buée L; Blum D
Diabetes; 2013 May; 62(5):1681-8. PubMed ID: 23250356
[TBL] [Abstract][Full Text] [Related]
2. Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22.
Kacířová M; Železná B; Blažková M; Holubová M; Popelová A; Kuneš J; Šedivá B; Maletínská L
J Neuroinflammation; 2021 Jun; 18(1):141. PubMed ID: 34158075
[TBL] [Abstract][Full Text] [Related]
3. Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model.
Leboucher A; Ahmed T; Caron E; Tailleux A; Raison S; Joly-Amado A; Marciniak E; Carvalho K; Hamdane M; Bantubungi K; Lancel S; Eddarkaoui S; Caillierez R; Vallez E; Staels B; Vieau D; Balschun D; Buee L; Blum D
Neurobiol Dis; 2019 May; 125():14-22. PubMed ID: 30665005
[TBL] [Abstract][Full Text] [Related]
4. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies.
Yarchoan M; Toledo JB; Lee EB; Arvanitakis Z; Kazi H; Han LY; Louneva N; Lee VM; Kim SF; Trojanowski JQ; Arnold SE
Acta Neuropathol; 2014 Nov; 128(5):679-89. PubMed ID: 25107476
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology.
Laurent C; Eddarkaoui S; Derisbourg M; Leboucher A; Demeyer D; Carrier S; Schneider M; Hamdane M; Müller CE; Buée L; Blum D
Neurobiol Aging; 2014 Sep; 35(9):2079-90. PubMed ID: 24780254
[TBL] [Abstract][Full Text] [Related]
6. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of tau phosphorylation and astroglial activation with enhanced leptin receptor expression in diet-induced obesity mouse hippocampus.
Koga S; Kojima A; Kuwabara S; Yoshiyama Y
Neurosci Lett; 2014 Jun; 571():11-6. PubMed ID: 24785100
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission.
Van der Jeugd A; Ahmed T; Burnouf S; Belarbi K; Hamdame M; Grosjean ME; Humez S; Balschun D; Blum D; Buée L; D'Hooge R
Neurobiol Learn Mem; 2011 Mar; 95(3):296-304. PubMed ID: 21167950
[TBL] [Abstract][Full Text] [Related]
9. Does obesity-induced τ phosphorylation tip the scale toward dementia?
Gendron TF; Zhang YJ; Petrucelli L
Diabetes; 2013 May; 62(5):1365-6. PubMed ID: 23613550
[No Abstract] [Full Text] [Related]
10. Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice.
Xiong J; Deng I; Kelliny S; Lin L; Bobrovskaya L; Zhou XF
Metab Brain Dis; 2022 Aug; 37(6):1941-1957. PubMed ID: 35704147
[TBL] [Abstract][Full Text] [Related]
11. Interaction Between a High-Fat Diet and Tau Pathology in Mice: Implications for Alzheimer's Disease.
Jang YJ; Choi MG; Yoo BJ; Lee KJ; Jung WB; Kim SG; Park SA
J Alzheimers Dis; 2024; 97(1):485-506. PubMed ID: 38108353
[TBL] [Abstract][Full Text] [Related]
12. High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status.
Takalo M; Haapasalo A; Martiskainen H; Kurkinen KM; Koivisto H; Miettinen P; Khandelwal VK; Kemppainen S; Kaminska D; Mäkinen P; Leinonen V; Pihlajamäki J; Soininen H; Laakso M; Tanila H; Hiltunen M
J Nutr Biochem; 2014 Jun; 25(6):634-41. PubMed ID: 24746833
[TBL] [Abstract][Full Text] [Related]
13. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
14. Effects of diet-induced obesity and voluntary exercise in a tauopathy mouse model: implications of persistent hyperleptinemia and enhanced astrocytic leptin receptor expression.
Koga S; Kojima A; Ishikawa C; Kuwabara S; Arai K; Yoshiyama Y
Neurobiol Dis; 2014 Nov; 71():180-92. PubMed ID: 25132556
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Abnormalities and Synaptic Loss Underlie Memory Deficits Seen in Mouse Models of Obesity and Alzheimer's Disease.
Martins IV; Rivers-Auty J; Allan SM; Lawrence CB
J Alzheimers Dis; 2017; 55(3):915-932. PubMed ID: 27802235
[TBL] [Abstract][Full Text] [Related]
16. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
17. A mouse model to study tau pathology related with tau phosphorylation and assembly.
Engel T; Lucas JJ; Hernández F; Avila J
J Neurol Sci; 2007 Jun; 257(1-2):250-4. PubMed ID: 17362999
[TBL] [Abstract][Full Text] [Related]
18. Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach.
Troquier L; Caillierez R; Burnouf S; Fernandez-Gomez FJ; Grosjean ME; Zommer N; Sergeant N; Schraen-Maschke S; Blum D; Buee L
Curr Alzheimer Res; 2012 May; 9(4):397-405. PubMed ID: 22272619
[TBL] [Abstract][Full Text] [Related]
19. MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance.
García-Gómez BE; Fernández-Gómez FJ; Muñoz-Delgado E; Buée L; Blum D; Vidal CJ
J Mol Neurosci; 2016 Apr; 58(4):411-5. PubMed ID: 26697857
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
